| scholarly article | Q13442814 |
| P2093 | author name string | Lees KR | |
| Murray GD | |||
| Dyker AG | |||
| Weir CJ | |||
| P433 | issue | 7090 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hyperglycemia | Q271993 |
| P304 | page(s) | 1303-1306 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study | |
| P478 | volume | 314 |
| Q36566267 | 21st century stroke--A medical emergency |
| Q36462304 | A population-based analysis of ethnic differences in admission to the intensive care unit after stroke |
| Q74257196 | A prognostic index for 30-day mortality after stroke |
| Q48548632 | A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients |
| Q73238461 | Acute Ischemic Stroke |
| Q35324130 | Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance |
| Q44060062 | Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. |
| Q33919326 | Acute ischemic stroke management |
| Q36308664 | Acute stroke and diabetes |
| Q47906477 | Acute stroke treatment in Europe: a questionnaire-based survey on behalf of the EFNS Task Force on acute neurological stroke care. |
| Q35486572 | Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study |
| Q36079045 | Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes? |
| Q37139530 | Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis |
| Q33590729 | Aggressive glucose control for acute ischemic stroke patients by insulin infusion |
| Q43054863 | An evidence-based practice approach to improving nursing care of acute stroke in an Australian Emergency Department |
| Q35756552 | Assessment and therapy of selected endocrine disorders |
| Q36835905 | Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke |
| Q51568697 | Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. |
| Q40173202 | Barriers and enablers to implementing clinical treatment protocols for fever, hyperglycaemia, and swallowing dysfunction in the Quality in Acute Stroke Care (QASC) Project--a mixed methods study. |
| Q51380164 | Beta-cell dysfunction and insulin resistance after subarachnoid haemorrhage. |
| Q36947210 | Blood glucose control in critical care patients - a review of the literature |
| Q46094875 | Blood glucose in acute stroke |
| Q43977282 | Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke |
| Q24801875 | Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality |
| Q35746772 | Cerebral protection |
| Q36060431 | Challenges in the diagnosis and treatment of pediatric stroke |
| Q50668780 | Changes to volumetric bone mineral density and bone strength after stroke: a prospective study. |
| Q35282066 | Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model |
| Q37350971 | Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke |
| Q38074569 | Clinical predictors and management of hemorrhagic transformation |
| Q44315584 | Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial |
| Q39419831 | Complementary examinations other than neuroimaging and neurosonology in acute stroke |
| Q37481675 | Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11. |
| Q37968783 | Complications of intracerebral haemorrhage |
| Q35067529 | Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients |
| Q31155725 | Creating diagnostic scores using data-adaptive regression: An application to prediction of 30-day mortality among stroke victims in a rural hospital in India |
| Q52096569 | Critical Care Management of Acute Ischemic Stroke. |
| Q37632812 | Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes |
| Q39427190 | Diabetes mellitus and stroke: A clinical update |
| Q38612827 | Diet-induced vitamin D deficiency has no effect on acute post-stroke outcomes in young male mice |
| Q64257908 | Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke |
| Q35009572 | Does early postresuscitation stress hyperglycemia affect 72-hour neurologic outcome? Preliminary observations in the Swine model |
| Q74598571 | Does neuroprotection improve stroke outcome? |
| Q40834591 | Drug therapy for acute ischaemic stroke: risks versus benefits |
| Q36871843 | EMS management of acute stroke--out-of-hospital treatment and stroke system development (resource document to NAEMSP position statement). |
| Q40898682 | Edaravone offers neuroprotection for acute diabetic stroke patients |
| Q44015749 | Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. |
| Q33610057 | Effect of hyperglycemia on brain penetrating arterioles and cerebral blood flow before and after ischemia/reperfusion |
| Q36283936 | Effects of alteplase in the treatment of acute ischemic stroke |
| Q45023598 | Effects of exogenous glucose on brain ischemia in ovine fetuses |
| Q43187764 | Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study |
| Q36096015 | Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART. |
| Q28165811 | Emergency Department Presentation of Pediatric Stroke |
| Q43100507 | Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage. |
| Q48208128 | Energy expenditure in ischemic stroke patients treated with moderate hypothermia |
| Q90113343 | European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke |
| Q47112860 | Evaluation of anticoagulation status for atrial fibrillation on early ischaemic stroke outcomes: a registry-based, prospective cohort study of acute stroke care in Surrey, UK. |
| Q48397827 | Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison. |
| Q45166063 | Feasibility of a quality assurance programme of bedside blood glucose testing in a hospital setting: 7 years' experience |
| Q33537949 | From stroke unit care to stroke care unit |
| Q36986422 | General care in stroke: relevance of glycemia and blood pressure levels. |
| Q37269848 | General principles of acute stroke management |
| Q48203239 | Glucose and the ischaemic brain: too much of a good thing? |
| Q43274550 | Glucose level and brain infarction: a prospective case-control study and prospective study |
| Q30823934 | Glucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans. |
| Q53238463 | Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). |
| Q37640683 | Glycemic control in critically ill patients. |
| Q35752364 | Hemorrhage Rates and Outcomes When Using up to 100 mg Intra-Arterial t-PA for Thrombolysis in Acute Ischemic Stroke |
| Q35740948 | Hemorrhagic stroke in children |
| Q42096952 | Higher Blood Glucose within the Normal Range Is Associated with More Severe Strokes |
| Q36331037 | Homeostasis as basis of acute stroke treatment: stroke units are the key. |
| Q92180198 | Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study |
| Q34125390 | Hospital management of diabetes |
| Q37820899 | Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis |
| Q44899930 | Hyperglycaemia and mortality in critically ill patients. A prospective study |
| Q55429937 | Hyperglycaemia and mortality. |
| Q47204540 | Hyperglycaemia and the SOAR stroke score in predicting mortality. |
| Q44923928 | Hyperglycaemia in acute lacunar stroke: a Chinese hospital-based study |
| Q35185150 | Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes? |
| Q37216100 | Hyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome. |
| Q45286825 | Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke |
| Q36521250 | Hyperglycemia in acute ischemic stroke: a vascular perspective. |
| Q36035243 | Hyperglycemia in the hospital setting: the case for improved control among non-diabetics |
| Q36616828 | Hyperglycemia is a predictor of prognosis in traumatic brain injury: Tertiary intensive care unit study |
| Q39348943 | Hyperglycemia is associated with more severe cytotoxic injury after stroke. |
| Q51480051 | Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. |
| Q51798169 | Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke. |
| Q60911535 | Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study |
| Q38603367 | In-hospital metabolic regulation in patients with a diabetic foot ulcer: is it worthwhile? |
| Q39150508 | Increased Short-Term Mortality in Patients with Spontaneous Intracerebral Hemorrhage and its Association with Admission Glucose Levels and Leukocytosis |
| Q35570132 | Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases |
| Q48385960 | Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke |
| Q37780914 | Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge |
| Q31898221 | Influence of D- and L-glucose on erythrocytes and blood viscosity |
| Q35756327 | Inpatient diabetology. The new frontier |
| Q24201046 | Insulin for glycaemic control in acute ischaemic stroke |
| Q24234214 | Insulin for glycaemic control in acute ischaemic stroke |
| Q24243588 | Insulin for glycaemic control in acute ischaemic stroke |
| Q49383181 | Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years. |
| Q33887000 | Intensive care unit management of the stroke patient. |
| Q33203601 | Intensive insulin therapy for critically ill patients |
| Q24246821 | Interventions for controlling hyperglycaemia in acute ischaemic stroke |
| Q44165238 | Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality |
| Q43597112 | Intraoperative physiologic variables and outcome in cardiac surgery: Part II. Neurologic outcome |
| Q91965160 | Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats |
| Q38004236 | Ischemia-induced hyperglycemia: consequences, neuroendocrine regulation, and a role for RAGE. |
| Q42045398 | Lipid and glucose profile in patients with ischemic cerebrovascular accidents in Dakar |
| Q33795568 | Maintenance of Normoglycemia May Improve Outcome in Acute Ischemic Stroke |
| Q38882917 | Management of Hyperglycemia in Critical Illness: Review of Targets and Strategies |
| Q28196668 | Management of acute stroke |
| Q26829870 | Managing post stroke hyperglycaemia: moderate glycaemic control is better? An update |
| Q34271952 | Medical therapy for acute ischemic stroke |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q35187308 | Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study. |
| Q33747433 | Neuroprotection in acute ischaemic stroke. II: Clinical potential |
| Q55499473 | Outcome Prediction in Acute Stroke Patients by Continuous Glucose Monitoring. |
| Q34703702 | Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations |
| Q35073398 | Perioperative infusions in paediatric patients: rationale for using Ringer-lactate solution with low dextrose concentration |
| Q37014893 | Physiological monitoring in acute stroke: a literature review |
| Q36599453 | Point-of-care capillary HbA1c measurement in the emergency department: a useful tool to detect unrecognized and uncontrolled diabetes |
| Q49025533 | Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome |
| Q41809350 | Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction |
| Q33930900 | Prediction of hospital mortality from admission laboratory data and patient age: a simple model. |
| Q46191310 | Predictors of hematoma expansion predictors after intracerebral hemorrhage |
| Q41007776 | Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke |
| Q41619928 | Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke |
| Q33887006 | Predictors of stroke outcome |
| Q50534955 | Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. |
| Q34261457 | Prevalence, Predictors and Prognosis of Post-Stroke Hyperglycaemia in Acute Stroke Trials: Individual Patient Data Pooled Analysis from the Virtual International Stroke Trials Archive (VISTA) |
| Q35760828 | Preventing a second stroke in the young |
| Q59000766 | Prognostic Value of Complete Blood Count and Electrolyte Panel during Emergency Department Evaluation for Acute Ischemic Stroke |
| Q41573199 | Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke |
| Q37335891 | Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study |
| Q48925891 | Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier |
| Q37222956 | Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. |
| Q50799446 | Risk factor burden predicts long-term mortality after cerebral infarction. |
| Q48468494 | Risk factors for short-term mortality in older subjects with acute ischemic stroke. |
| Q37202149 | Safety and efficacy of alteplase in the treatment of acute ischemic stroke |
| Q43212514 | Secondary prevention for stroke and transient ischaemic attacks: Horizons needs expanding |
| Q44051664 | Serum fructosamine as a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia |
| Q36659721 | Sex differences and hemoglobin levels in relation to stroke outcomes |
| Q46876139 | Smoking predicts long-term mortality in stroke: The European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study |
| Q47825623 | Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th |
| Q32060199 | Stress-induced hyperglycemia |
| Q38543801 | Stroke associated with coronary artery bypass grafting |
| Q46716543 | Stroke in diabetic and non-diabetic patients: course and prognostic value of admission serum glucose |
| Q50758959 | Stroke unit care, inpatient rehabilitation and early supported discharge. |
| Q34795617 | Stroke: a review with an African perspective |
| Q37759025 | Sugar and stroke: cerebrovascular disease and blood glucose control. |
| Q38001593 | The diagnosis and management of cerebrovascular disease in diabetes. |
| Q44031194 | The effects of early insulin treatment combined with thrombolysis in rat embolic stroke |
| Q33917662 | The evolution of stroke units-towards a more intensive approach? |
| Q36651170 | The role of hyperglycemia in acute ischemic stroke |
| Q35600806 | The roles of insulin and hyperglycemia in sepsis pathogenesis. |
| Q34107350 | Thrombolysis for acute stroke: is it for everyone? |
| Q43727686 | Transient hyperglycemia in ischemic stroke patients |
| Q37774957 | Treating hyperglycemia in neurocritical patients: benefits and perils. |
| Q51527048 | Type 2 Diabetes Mellitus and Insulin Resistance: Stroke Prevention and Management. |
| Q51492970 | Undiagnosed dysglycaemia and inflammation in cardiovascular disease. |
| Q38864117 | Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke. |
| Q44287733 | Validation of a glucose-insulin-potassium infusion algorithm in hospitalized diabetic patients |
| Q48406713 | Variation in the management of acute physiological parameters after ischaemic stroke: a European perspective. |
| Q34056942 | Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? |
| Q83105682 | [Diabetes and cerebrovascular disease] |
| Q45938559 | [Repercussions and management of perioperative hyperglycemia in cardiac surgery] |
| Q73591839 | [The multidisciplinary care of acute cerebral stroke] |
Search more.